TSPYL5 and cancer: In conclusion, these results suggest that phosphorylation of TSPYL5 at threonine-120 is essential for eliciting cancer stemness and inherent or acquired resistance of NSCLC cells to radiation or targeted drugs, and that TS120-T peptides may be used to sensitize CSC-like NSCLC cells to these therapies.